Biotech Lessons on Running Companies Like Products
What biotech R&D teams get right about empiricism that software teams lose sight of, and what the cross-pollination looks like in practice.
Read more →Making sense of agility, scaling, OKRs, product operating models, and leadership — written from 15+ years in the field.
What biotech R&D teams get right about empiricism that software teams lose sight of, and what the cross-pollination looks like in practice.
Read more →Is SAFe good? Is SAFe agile? As a SAFe Fellow and Professional Scrum Trainer, I break down SAFe's real strengths, weaknesses, and controversies using my own words from the Breaking the SAFe series.
Read more →Most transformation programs fail not because people resist change, but because they're run like projects instead of learning systems. Here's what works.
Read more →Flywheels need consistent turns, not one-time framework installs. Three agility flywheels worth building — and the doom loops that destroy them.
Read more →The agile industry teaches outcomes over outputs, then measures itself in certifications and butts on seats. Why that is economics, not character.
Read more →AI initiatives die in the proof-of-concept stage when run as fixed-scope projects. Clemens Adolphs and I unpack why AI work needs real product discovery.
Read more →